Cargando…
Operation of the percutaneous endoscopic gastrostomy-jejunostomy tube without endoscopy in patients with Parkinson’s disease on levodopa-carbidopa intestinal gel infusion therapy
INTRODUCTION: Tube-related adverse events (AEs) occur frequently in patients with Parkinson’s disease (PD) receiving levodopa-carbidopa intestinal gel therapy. Endoscopy has become evasive since the beginning of the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to evaluate methods t...
Autores principales: | Mukai, Yohei, Toyoda, Hiroyuki, Miyama, Kenji, Takahashi, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298846/ https://www.ncbi.nlm.nih.gov/pubmed/34316657 http://dx.doi.org/10.1016/j.prdoa.2020.100079 |
Ejemplares similares
-
Delayed Diagnosis of Buried Bumper Syndrome When Only the Jejunostomy Extension is Used in a Percutaneous Endoscopic Gastrostomy-jejunostomy Levodopa-carbidopa Intestinal Gel Delivery System
por: Abu-Heija, Ahmad A, et al.
Publicado: (2019) -
Transgastric Jejunostomy (PEG-J) for Continuous Infusion of Levodopa-Carbidopa Intestinal Gel: An Approach for Parkinson’s Disease Treatment
por: Nomoto, Yusuke, et al.
Publicado: (2023) -
Percutaneous Endoscopic Gastrostomy, Duodenostomy and Jejunostomy
por: Nishiguchi, Yukio, et al.
Publicado: (1994) -
Long‐term safety and effectiveness of levodopa‐carbidopa intestinal gel infusion
por: De Fabregues, Oriol, et al.
Publicado: (2017) -
Percutaneous endoscopic gastrostomy and jejunostomy: Indications and techniques
por: Fugazza, Alessandro, et al.
Publicado: (2022)